Naturally occurring variation in the glutathione-s-transferase 4 gene determines neurodegeneration after traumatic brain injury

Antioxidants and Redox Signaling

Volumn 18, Issue 7, 2013, Pages 784-794

  Al Nimer, Faiez ^a   Ström, Mikael ^a   Lindblom, Rickard ^a   Aeinehband, Shahin ^a   Bellander, Bo Michael ^a   Nyengaard, Jens R ^b   Lidman, Olle ^a   Piehl, Fredrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CONGENIC STRAIN; CONTROLLED STUDY; DARK AGOUTI STRAIN; GENE EXPRESSION; GENE INSERTION; GENETIC DIFFERENCE; GENETIC VARIABILITY; GLUTATHIONE METABOLISM; HAPLOTYPE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NERVE CELL; NERVE DEGENERATION; NEUROFILAMENT; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RAT STRAIN; STRAIN DIFFERENCE; TPIEBALD VIROL GLAXO STRAIN; TRAUMATIC BRAIN INJURY; UPREGULATION;

ALDEHYDES; ANIMALS; BRAIN INJURIES; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LIPID PEROXIDATION; MALE; MICE; MICE, TRANSGENIC; NEURONS;

EID: 84872965109     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4440     Document Type: Article

References (49)

1. Abel EL, Angel JM, Riggs PK, Langfield L, Lo HH, Person MD, Awasthi YC, Wang LE, Strom SS, Wei Q, and DiGio-vanni J. Evidence that Gsta4 modifies susceptibility to skin tumor development in mice and humans. J Natl Cancer Inst 102: 1663-1675, 2010.
2. Al Nimer F, Beyeen AD, Lindblom R, Strom M, Aeinehband S, Lidman O, and Piehl F. Both MHC and non-MHC genes regulate inflammation and T-cell response after traumatic brain injury. Brain Behav Immun 25: 981-990, 2011.
3. Arakawa M, Ishimura A, Arai Y, Kawabe K, Suzuki S, Ishige K, and Ito Y. N-Acetylcysteine and ebselen but not nifedipine protected cerebellar granule neurons against 4-hydroxynonenal-induced neuronal death. Neurosci Res 57: 220-229, 2007.
4. Balogh LM and Atkins WM. Interactions of glutathione transferases with 4-hydroxynonenal. Drug Metab Rev 43: 165-178, 2011.
5. Beyeen AD, Adzemovic MZ, Ockinger J, Stridh P, Becanovic K, Laaksonen H, Lassmann H, Harris RA, Hillert J, Al-fredsson L, Celius EG, Harbo HF, Kockum I, Jagodic M, and Olsson T. IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroin-flammation. J Immunol 185: 6883-6890, 2010.
6. Coppede F, Armani C, Bidia DD, Petrozzi L, Bonuccelli U, and Migliore L. Molecular implications of the human glu-tathione transferase A-4 gene (hGSTA4) polymorphisms in neurodegenerative diseases. Mutat Res 579: 107-114, 2005.
7. Costantini D, Ferrari C, Pasquaretta C, Cavallone E, Carere C, von Hardenberg A, and Reale D. Interplay between plasma oxidative status, cortisol and coping styles in wild alpine marmots, Marmota marmota. J Exp Biol 215: 374-383, 2012.
8. Dahlman I, Lorentzen JC, de Graaf KL, Stefferl A, Linington C, Luthman H, and Olsson T. Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; Impact onseverity ofmyelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern. Eur J Immunol 28: 2188-2196, 1998.
9. Di Pietro G, Magno LA, and Rios-Santos F. Glutathione S-transferases: An overview in cancer research. Expert Opin Drug Metab Toxicol 6: 153-170, 2010.
10. Dorph-Petersen KA, Nyengaard JR, and Gundersen HJ. Tissue shrinkage and unbiased stereological estimation of particle number and size. J Microsc 204: 232-246, 2001.
11. Ferguson S, Mouzon B, Kayihan G, Wood M, Poon F, Doore S, Mathura V, Humphrey J, O'Steen B, Hayes R, Roses A, Mullan M, and Crawford F. Apolipoprotein E genotype and oxidative stress response to traumatic brain injury. Neu-roscience 168: 811-819, 2010.
12. Galvani S, Coatrieux C, Elbaz M, Grazide MH, Thiers JC, Parini A, Uchida K, Kamar N, Rostaing L, Baltas M, Salvayre R, and Negre-Salvayre A. Carbonyl scavenger and anti-atherogenic effects of hydrazine derivatives. Free Radic Biol Med 45: 1457-1467, 2008.
13. Gillett A, Marta M, Jin T, Tuncel J, Leclerc P, Nohra R, Lange S, Holmdahl R, Olsson T, Harris RA, and Jagodic M. TNF production in macrophages is genetically determined and regulates inflammatory disease in rats. J Immunol 185: 442-450, 2010.
14. Gilmer LK, Ansari MA, Roberts KN, and Scheff SW. Age-related mitochondrial changes after traumatic brain injury. J Neurotrauma 27: 939-950, 2010.
15. Gulko PS. Contribution of genetic studies in rodent models of autoimmune arthritis to understanding and treatment of rheumatoid arthritis. Genes Immun 8: 523-531, 2007.
16. Hall ED, Vaishnav RA, and Mustafa AG. Antioxidant therapies for traumatic brain injury. Neurotherapeutics 7: 51-61, 2010.
17. Hwang JJ, Lee SJ, Kim TY, Cho JH, and Koh JY. Zinc and 4-hydroxy-2-nonenal mediate lysosomal membrane per-meabilization induced by H2O2 in cultured hippocampal neurons. J Neurosci 28: 3114-3122, 2008.
18. Itoh T, Satou T, Nishida S, Tsubaki M, Imano M, Hashimoto S, and Ito H. Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats. Neurochem Res 35: 348-355, 2010.
19. Lidman O, Swanberg M, Horvath L, Broman KW, Olsson T, and Piehl F. Discrete gene loci regulate neurodegeneration, lymphocyte infiltration, and major histocompatibility complex class II expression in the CNS. J Neurosci 23: 9817-9823, 2003.
20. Lingsma HF, Roozenbeek B, Steyerberg EW, Murray GD, and Maas AI. Early prognosis in traumatic brain injury: From prophecies to predictions. Lancet Neurol 9: 543-554, 2010.
21. Liu H, Wang H, Shenvi S, Hagen TM, and Liu RM. Glu-tathione metabolism during aging and in Alzheimer disease. Ann NY Acad Sci 1019: 346-349, 2004.
22. Lundberg C, Lidman O, Holmdahl R, Olsson T, and Piehl F. Neurodegeneration and glial activation patterns after mechanical nerve injury are differentially regulated by non-MHC genes in congenic inbred rat strains. J Comp Neurol 431: 75-87, 2001.
23. Maes OC, Schipper HM, Chong G, Chertkow HM, and Wang E. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease. Neurobiol Aging 31: 34-45, 2010.
24. Marklund N, Bakshi A, Castelbuono DJ, Conte V, and Mc-Intosh TK. Evaluation of pharmacological treatment strategies in traumatic brain injury. Curr Pharm Des 12: 1645-1680, 2006.
25. Matsuda S, Umeda M, Uchida H, Kato H, and Araki T. Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats. J Neural Transm 116: 395-404, 2009.
26. McAllister TW. Genetic factors modulating outcome after neurotrauma. PM R 2: S241-252, 2010.
27. McCracken E, Valeriani V, Simpson C, Jover T, McCulloch J, and Dewar D. The lipid peroxidation by-product 4-hydro-xynonenal is toxic to axons and oligodendrocytes. J Cereb Blood Flow Metab 20: 1529-1536, 2000.
28. McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, Michielli RA, Shen FM, Evans AA, London WT, and Buetow KH. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res 63: 4594-4601, 2003.
29. Ockinger J, Stridh P, Beyeen AD, Lundmark F, Seddighza-deh M, Oturai A, Sorensen PS, Lorentzen AR, Celius EG, Leppa V, Koivisto K, Tienari PJ, Alfredsson L, Padyukov L, Hillert J, Kockum I, Jagodic M, and Olsson T. Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes Immun 11: 142-154, 2010.
30. Perez-Pastene C, Graumann R, Diaz-Grez F, Miranda M, Venegas P, Godoy OT, Layson L, Villagra R, Matamala JM, Herrera L, and Segura-Aguilar J. Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component. Neu-rosci Lett 418: 181-185, 2007.
31. Piehl F and Olsson T. Inflammation and susceptibility to neu-rodegeneration: The use of unbiased genetics to decipher critical regulatory pathways. Neuroscience 158: 1143-1150, 2009.
32. Qian J, Jing J, Jin G, Wang H, Wang Y, Liu H, Li R, Fan W, An Y, Sun W, Ma H, Miao R, Hu Z, Jin L, Wei Q, Shen H, Huang W, and Lu D. Association between polymorphisms in the GSTA4 gene and risk of lung cancer: A case-control study in a Southeastern Chinese population. Mol Carcinog 48: 253-259, 2009.
33. Radu RA, Hu J, Yuan Q, Welch DL, Makshanoff J, Lloyd M, McMullen S, Travis GH, and Bok D. Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration. J Biol Chem 286: 18593-18601, 2011.
34. Reid WM, Rolfe A, Register D, Levasseur JE, Churn SB, and Sun D. Strain-related differences after experimental traumatic brain injury in rats. J Neurotrauma 27: 1243-1253, 2010.
35. Salzer J, Svenningsson A, and Sundstrom P. Neurofilament light as a prognostic marker in multiple sclerosis. Mult Scler 16: 287-292, 2010.
36. Sawcer S. Bayes factors in complex genetics. Eur J Hum Genet 18: 746-750, 2010.
37. Schulz JB, Lindenau J, Seyfried J, and Dichgans J. Glu-tathione, oxidative stress and neurodegeneration. Eur J Bio-chem 267: 4904-4911, 2000.
38. Selley ML. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med 25: 169-174, 1998.
39. Selley ML, Close DR, and Stern SE. The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging 23: 383-388, 2002.
40. Shao C, Roberts KN, Markesbery WR, Scheff SW, and Lovell MA. Oxidative stress in head trauma in aging. Free Radic Biol Med 41: 77-85, 2006.
41. Simpson EP, Henry YK, Henkel JS, Smith RG, and Appel SH. Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology 62: 1758-1765, 2004.
42. Strom M, Al Nimer F, Lindblom R, Nyengaard JR, and Piehl F. Naturally occurring genetic variability in expression of Gsta4 is associated with differential survival of axotomized rat motoneurons. Neuromol Med 14: 15-29, 2012.
43. Swanberg M, Harnesk K, Strom M, Diez M, Lidman O, and Piehl F. Fine mapping of gene regions regulating neurode-generation. PLoS One 4: e5906, 2009.
44. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Borjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F, and Olsson T. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37: 486-494, 2005.
45. Tan AA, Quigley A, Smith DC, and Hoane MR. Strain differences in response to traumatic brain injury in Long-Evans compared to Sprague-Dawley rats. J Neurotrauma 26: 539-548, 2009.
46. Tang SC, Arumugam TV, Cutler RG, Jo DG, Magnus T, Chan SL, Mughal MR, Telljohann RS, Nassar M, Ouyang X, Calderan A, Ruzza P, Guiotto A, and Mattson MP. Neuro-protective actions of a histidine analogue in models of is-chemic stroke. J Neurochem 101: 729-736, 2007.
47. Townsend DM, Tew KD, and Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 57: 145-155, 2003.
48. Yao X. Effect of zinc exposure on HNE and GLT-1 in spinal cord culture. Neurotoxicology 30: 121-126, 2009.
49. Zhou W, Xu D, Peng X, Zhang Q, Jia J, and Crutcher KA. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma 25: 279-290, 2008.